An influenza medicine developed by a Fujifilm Holdings group member is effective against the novel coronavirus, the Chinese government said Tuesday.
The government has already begun officially recommending the drug’s use.
Fujifilm Toyama Chemical developed favipiravir, sold under the brand Avigan.
“It has a high degree of safety and is clearly effective in treatment,” said Zhang Xinmin, director of the science ministry’s China National Center for Biotechnology Development, in a news conference. Fujifilm Toyama Chemical developed the drug in 2014, and it has been provided to patients in Japan as treatment for the novel coronavirus since February.
On Wednesday, shares in Japan’s Fujifilm opened at their daily limit. At 5,238, they were 15% higher than the previous day’s close in Tokyo.
Zhejiang Hisun Pharmaceutical signed a patent-licensing agreement for favipiravir with Fujifilm in 2016. The drugmaker received clearance to produce the drug from Chinese authorities in February and can ramp up output of a generic version.
The clinical trial was conducted at hospitals in Wuhan and Shenzhen, with 200 patients participating. Test results for those receiving the drug turned negative in a shorter period, and their pneumonia symptoms improved at a higher rate.
Latest Stories
-
King Charles to resume public duties after progress in cancer treatment
18 mins -
Arda Guler scores on first start in La Liga as Madrid beat Real Sociedad
28 mins -
Fatawu Issahaku’s Leicester City secures Premier League promotion after Leeds defeat
40 mins -
Anticipation builds as Junior Speller hosts nationwide auditions
1 hour -
Etse Sikanku: The driver’s mate conundrum
2 hours -
IMF Deputy Chief worried large chunk of Eurobonds is used to service debt
2 hours -
Otumfuo Osei Tutu II celebrates 25 years of peaceful rule on golden stool
2 hours -
We have enough funds to pay accruing benefits; we’ve never missed pension payments since 1991 – SSNIT
2 hours -
Let’s embrace shared vision and propel National Banking College – First Deputy Governor
3 hours -
Liverpool agree compensation deal with Feyenoord for Slot
3 hours -
Ejisu by-election: There’s no evidence of NPP engaging in vote-buying – Ahiagbah
3 hours -
Ejisu by-election: Independent ex-NPP MP’s campaign team warns party against dubious tactics
4 hours -
ZEN Petroleum supports Tse-Addo Future Leaders School
4 hours -
NPP must win back Adentan seat in 2024 polls – Obeng Fosu
5 hours -
PPA Clarification: The dark side of the World Bank’s ‘giveaways’ in Ghana by Bright Simons
6 hours